Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • FIRST: Needle, syringe...

    FIRST: Needle, syringe makers tell government to regulate their prices

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-09-26T15:41:26+05:30  |  Updated On 23 Dec 2022 10:49 AM IST
    FIRST: Needle, syringe makers tell government to regulate their prices
    New Delhi: All India Syringes and Needles Manufacturers Association (AISNMA) has written a letter to NELM on price capping of essential syringes and needles. It is probably the first time when any manufacturing association has itself sought price control. al.

    Medical Dialogues had earlier reported that in order to make the consumables and medical devices affordable to the patients, manufacturers of disposable syringes had voluntarily decided to put a ceiling on trade margins at 75 per cent after NPPA called a meeting in this matter.

    The All India Syringes and Needles Manufacturers Association had issued a circular to its members to print the maximum retail price (MRP) on the basis of a maximum of 75% margin with effect. The policy move covers all categories of syringes and needles – disposable, auto-disable, reuse prevention, needle stick prevention, insulin pen needle etc.

    Read Also: Limit on Trade Margins -Medical syringe makers to cut prices soon


    The self regulation came after the National Pharmaceutical Pricing Authority (NPPA) based on the available data from official sources, manufactures and importers analyzed the trade margins in the syringes and needles and found that the manufactures were hiking their prices more than 1000 per cent, from the cost of the manufacturing to the price at which they're sold to consumers. According to NPPA data, the maximum trade margin in the case of the syringes is as high as 214% to 1251%. While in the case of needles it is as high as 57% to 789%.

    Read Also: Syringes and needles being sold at 214 to 1251 per cent margin: NPPA

    However, four companies — Lifelong Meditech, Becton Dickinson, B Braun Medical and NIPRO Medical — did not follow the advisory, prompting the association to ask the government to come out with formal regulations over their prices

    Rajiv Nath, president, All India Syringes and Needles Manufacturers Association (AISNMA) told
    TOI
    , adding, "We want a level playing field. Hospitals need not sell at the MRP and are free to sell under it, but doctors have been blaming us (manufacturers) for high prices. With price caps or cap on trade margins, our endeavour is to make hospitals focus on making the procurement decision on the quality of the medical device and cost minimisation, rather than the current skewed practice of higher margins and profit maximisation. This has taken away the motivation of hospitals to be cost competitive, and patients feel exploited leading to a trust deficit."

    Earlier, CIC probe on Max Hospital and Beckton Dickson India Pvt. Ltd, a manufacturer of disposable syringes, who had come under CCI after an allegation by the patient that the latter is provided syringes exclusively to the hospital. It had been alleged that Beckton Dickson was supplying Max Hospital disposable syringe exclusively, which mean that they are only Beckton Syringes available in the hospital. Further, it was alleged that the same was supplied to the patients at higher than MRP Cost( at the hospital premise).

    Read Also: Max Hospital alleged overcharging on Syringes leads to CCI probe on all Super-Speciality hospitals in Delhi
    AISNMAAll India Syringes and Needles Manufacturers AssociationallegationsB Braun MedicalBecton DickinsonCICCIC probeLifelong MeditechMax HospitalNational List of Essential MedicinesNational Pharmaceuticals Pricing AuthorityNIPRO MedicalNLEMNPPARajiv Nathunscrupulous marketing

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok